Building Economic Resilience to the Health Impacts of Climate Change 2025

Page 31 of 49 · WEF_Building_Economic_Resilience_to_the_Health_Impacts_of_Climate_Change_2025.pdf

5.4 Interventions Healthcare providers and businesses can act to protect their workforce and the communities they serve while capturing new economic opportunities. Health and healthcare interventions TABLE 8 As dengue escalates due to climate change, Takeda’s vaccine offers a critical preventive tool. Now, through active participation in the Collective Action on Dengue (CAD) initiative, Takeda is helping scale climate-resilient healthcare by aligning innovation with cross-sector coordination. The coalition, launched at the 2023 United Nations Climate Change Conference (COP28) and supported by over 30 stakeholders, cultivates collaboration across urban health, innovation and financing. Takeda contributes technical and strategic expertise, accelerating access to vaccines and strengthening health systems in climate-vulnerable regions. By working through the coalition, Takeda helps integrate vaccination into broader prevention strategies – ensuring equitable delivery, informing policy and advancing joint planning. Overall, this partnership drives scalable, sustainable dengue prevention in an era of rising climate risk.Takeda and the Collective Action on Dengue initiative BOX 81 Develop novel drugs, products and services Pharmaceutical and medical device companies can adapt their R&D pipelines to address shifting disease patterns, emerging pathogens and conditions driven by climate change. In this effort, improved forecasting will be critical to unlocking investment and scaling innovation.Developing novel drugs, medical devices and diagnostics for climate-related illnesses is increasingly commercially attractive, with patient populations and demand growing across new markets. Similarly, care facilities can develop more effective patient treatment pathways (including community-based preventative care schemes), more efficiently treating those suffering from climate-related illnesses.Healthcare value chain Pharmaceuticals and life sciencesSystem-level care planning and administrationPatient care and treatment Interventions for consumers1 Develop novel drugs, products and services, focusing on diseases intensified by climate change.3 Establish care centres in climate-vulnerable regions (including telehealth and mobile care options equipped to address climate-health risks). 2 Improve climate resilience of existing portfolios of drugs, products and services, e.g. thermal stability of drugs. 4 Retrofit estates and care facilities to increase capacity for demand surges and ensure infrastructure is climate-resilient. 5 Scale up provision of preventative healthcare to mitigate the effects of climate-related illness. Interventions for the workforce6 Implement cooling solutions in healthcare facilities, as well as heat stress monitoring and management. 7 Protect workers with clothing/equipment and specialized training to raise awareness of growing climate health risks and reduce risk exposure. 8 Implement comprehensive mental health support for practitioners, including proactive strategies and treatment. Building Economic Resilience to the Health Impacts of Climate Change 31
Ask AI what this page says about a topic: